Study:
DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
Rationale:
n/a
Purpose:
This trial is a prospective, multi-center, randomized study of patients with coronary artery
disease (CAD) and mild to moderate left ventricular (LV) dysfunction. The primary objective
of this study is to test the hypothesis that Implantable Cardioverter Defibrillator (ICD)
therapy in combination with medical therapy in patients with an infarct size greater than or
equal to 10% of the left ventricular mass improves long term survival compared to medical
therapy alone. In addition to the 2-arm randomized trial, the study will also include a
non-investigational registry of non-randomized patients.
Study Status: Terminated
Recruiting:
n/a
| Condition |
Intervention |
Phase |
Coronary Artery Disease
Left Ventricular Dysfunction
Sudden Cardiac Death |
Device: Defibrillator
Other: Control |
N/A |
Verified by
St. Jude Medical
March, 2012
Sponsored by: St. Jude Medical
Information provided by: St. Jude Medical
ClinicalTrials.gov identifier: NCT00487279
Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
The Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States
Alan Kadish, MD., Principal Investigator